0001209191-22-013765.txt : 20220228 0001209191-22-013765.hdr.sgml : 20220228 20220228184625 ACCESSION NUMBER: 0001209191-22-013765 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220224 FILED AS OF DATE: 20220228 DATE AS OF CHANGE: 20220228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Quintana Marie CENTRAL INDEX KEY: 0001769891 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-07293 FILM NUMBER: 22692664 MAIL ADDRESS: STREET 1: 14201 DALLAS PARKWAY CITY: DALLAS STATE: TX ZIP: 75254 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TENET HEALTHCARE CORP CENTRAL INDEX KEY: 0000070318 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062] IRS NUMBER: 952557091 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 14201 DALLAS PARKWAY CITY: DALLAS STATE: TX ZIP: 75254 BUSINESS PHONE: 469-893-2200 MAIL ADDRESS: STREET 1: 14201 DALLAS PARKWAY CITY: DALLAS STATE: TX ZIP: 75254 FORMER COMPANY: FORMER CONFORMED NAME: NATIONAL MEDICAL ENTERPRISES INC /NV/ DATE OF NAME CHANGE: 19920703 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-02-24 0 0000070318 TENET HEALTHCARE CORP THC 0001769891 Quintana Marie 14201 DALLAS PARKWAY DALLAS TX 75254 0 1 0 0 EVP, Marketing/Communications Common Stock 2022-02-24 4 M 0 2680 A 4979 D Common Stock 2022-02-24 4 F 0 695 81.20 D 4284 D Common Stock 2022-02-25 4 M 0 5096 A 9380 D Common Stock 2022-02-25 4 F 0 1241 85.71 D 8139 D Common Stock 2022-02-25 4 M 0 2753 A 10892 D Common Stock 2022-02-25 4 F 0 671 85.71 D 10221 D 2021 February Restricted Stock Units 2022-02-24 4 M 0 2680 0.00 D Common Stock 2680 5362 D 2020 February Restricted Stock Units 2022-02-25 4 M 0 5096 0.00 D Common Stock 5096 5096 D 2019 February Restricted Stock Units 2022-02-25 4 M 0 2753 0.00 D Common Stock 2753 0 D As previously reported, on February 24, 2021, the reporting person received a grant of 8,042 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 24, 2022, resulting in the vesting and settlement of 2,680 shares of common stock, as shown in Table I. The remaining 5,362 restricted stock units are shown in Table II, of which 2,681 are scheduled to vest on each of February 24, 2023, and February 24, 2024. Restricted stock units convert into common stock on a one-for-one basis. Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. As previously reported, on February 26, 2020, the reporting person received a grant of 15,288 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 26, 2021, resulting in the vesting and settlement of 5,096 shares of common stock. The second anniversary occurred on February 25, 2022 (the business day prior to February 26, 2022, which fell on a weekend), resulting in the vesting and settlement of 5,096 shares of common stock, as shown in Table I. The remaining 5,096 restricted stock units are shown in Table II, and are scheduled to vest on February 26, 2023. As previously reported, on February 27, 2019, the reporting person received a grant of 8,257 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 27, 2020, resulting in the vesting and settlement of 2,752 shares of common stock. The second anniversary occurred on February 26, 2021 (the business day prior to February 27, 2021, which fell on a weekend), resulting in the vesting and settlement of 2,752 shares of common stock. The third anniversary occurred on February 25, 2022 (the business day prior to February 27, 2022, which fell on a weekend), resulting in the vesting and settlement of 2,753 shares of common stock, as shown in Table I. Time-based restricted stock units are settled in shares of the Company's common stock upon vesting. Chad J. Wiener, as Attorney-in-Fact for Marie Quintana 2022-02-28